These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12192603)

  • 41. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CDX2 as a useful marker of colorectal adenocarcinoma metastases to lung in pre-operative biopsy specimens.
    Tanaka S; Saito K; Ito T; Tajima K; Mogi A; Shitara Y; Sano T; Kuwano H
    Oncol Rep; 2007 Jul; 18(1):87-92. PubMed ID: 17549351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and prognostic implications of FOXO3a and Ki67 in lung adenocarcinomas.
    Liu HB; Gao XX; Zhang Q; Liu J; Cui Y; Zhu Y; Liu YF
    Asian Pac J Cancer Prev; 2015; 16(4):1443-8. PubMed ID: 25743813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
    Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
    Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
    Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of cytokeratins in glioblastoma multiforme.
    Terada T
    Pathol Oncol Res; 2015 Jul; 21(3):817-9. PubMed ID: 25633990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.
    Young GD; Winokur TS; Cerfolio RJ; Van Tine BA; Chow LT; Okoh V; Garver RI
    Lung Cancer; 2002 May; 36(2):133-41. PubMed ID: 11955647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.
    Zhong X; Li M; Nie B; Wu F; Zhang L; Wang E; Han Y
    Ann Surg Oncol; 2013 Mar; 20(3):1044-52. PubMed ID: 22592183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
    Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
    Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis.
    Fujiwara T; Hiramatsu M; Isagawa T; Ninomiya H; Inamura K; Ishikawa S; Ushijima M; Matsuura M; Jones MH; Shimane M; Nomura H; Ishikawa Y; Aburatani H
    Lung Cancer; 2012 Jan; 75(1):119-25. PubMed ID: 21737174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compensation of type I and type II cytokeratin pools in lung cancer.
    Kanaji N; Bandoh S; Fujita J; Ishii T; Ishida T; Kubo A
    Lung Cancer; 2007 Mar; 55(3):295-302. PubMed ID: 17161499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival.
    Matros E; Bailey G; Clancy T; Zinner M; Ashley S; Whang E; Redston M
    Cancer; 2006 Feb; 106(3):693-702. PubMed ID: 16362976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
    Chen Y; Knösel T; Kristiansen G; Pietas A; Garber ME; Matsuhashi S; Ozaki I; Petersen I
    J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
    Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
    Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokeratin and vimentin expression in normal and neoplastic canine prostate.
    Grieco V; Patton V; Romussi S; Finazzi M
    J Comp Pathol; 2003 Jul; 129(1):78-84. PubMed ID: 12859911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
    Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
    Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice.
    Rütters H; Zürbig P; Halter R; Borlak J
    Proteomics; 2006 May; 6(10):3127-37. PubMed ID: 16688788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.